MedTrace Logo

Impact of a Clinical Pathway for Pelvic Fragility Fractures

NCT06054165 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 393

Last updated 2024-06-24

No results posted yet for this study

Summary

Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice. New insights in treatment strategies, such as early diagnosis and minimal invasive operative treatment of these fragile patient population, has led to the development of several clinical pathways in recent literature. The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome.

Conditions

  • Pelvic Bone Injury
  • Sacral Fracture
  • Pelvic Fracture
  • Fragility Fracture

Interventions

OTHER

Clinical pathway

Evidence-based and expert-opinion-based clinical pathway regarding the diagnostic and treatment strategy

Sponsors & Collaborators

  • Noordwest Ziekenhuisgroep

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Frank W Bloemers, prof · Amsterdam UMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-21
Primary Completion
2025-04-27
Completion
2027-04-27

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06054165 on ClinicalTrials.gov